Larch Arabinogalactan for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Larch Arabinogalactan for Health & Longevity

Created on 06/18/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A soluble larch-wood fiber the body cannot digest, so it feeds gut bacteria and reliably shifts the gut toward beneficial microbes — its best-supported effect. It also modestly lowers how often healthy adults catch colds and strengthens antibody responses to bacterial vaccines. Inexpensive and well tolerated, mild gas and bloating the main drawback. Immune evidence is modest, with financial conflicts. (Full Review)

Protocol

Standard Dose
1.5–4.5 g/day
For immune support; 10–30 g/day for prebiotic/fiber intake
Starting Point
~1.5 g/day
Titrate upward over one to two weeks to target dose to minimize GI symptoms
Timing & Splitting
With meals
Splitting into two or three smaller doses with meals is better tolerated than one large dose
Time to effect
Prebiotic / Microbiome
A few weeks
Microbiome and short-chain fatty acid effects build over a few weeks of daily use
Reduced Cold Incidence
8–12 weeks
Cold-incidence benefit emerged over weeks to a few months in trials
Vaccine Antibody Response
8–12 weeks
Vaccine-antibody studies ran 8–12 weeks; not an acute, fast-acting agent

Benefits

Contraindications
  • Known larch/conifer allergy
  • Organ-transplant recipients and others on immunosuppressants (avoid unless supervised)
    •
Key Interactions
  • Oral medications (separate by 1–2 hours)
  • Antibiotics
  • Immunosuppressant drugs (corticosteroids, calcineurin inhibitors such as cyclosporine, tacrolimus)
  • Other immune-stimulating supplements (echinacea, beta-glucans, medicinal mushrooms)
  • Other prebiotics and fermentable fibers (inulin, fructooligosaccharides)
  • Over-the-counter medications
    •

Risk & Side Effects

  • High: Gastrointestinal symptoms
    •
  • Medium: Symptom severity during established infections
    •
  • Low: Allergic or hypersensitivity reactions
    •
  • Speculative: Unwanted immune activation in autoimmune or inflammatory conditions; excessive fermentation in disordered gut conditions
    •

Monitoring

Marker Target Why
hs-CRP < 1.0 mg/L General marker of body-wide inflammation
Complete blood count (CBC) with differential Within standard reference range Reflects overall immune-cell populations over time
Stool short-chain fatty acids (acetate, propionate, butyrate) Higher butyrate proportion favorable Direct readout of fermentation behind the prebiotic benefit
Stool microbiome composition (Bifidobacterium/Lactobacillus) Increased beneficial genera vs. baseline Confirms the fiber is shifting gut bacteria as intended
Blood urea nitrogen (BUN) 10–18 mg/dL Tracks nitrogenous waste; relevant for the kidney-support use

Cadence: Recheck hs-CRP and CBC at ~8–12 weeks after starting, then every 6–12 months; repeat stool microbiome/short-chain fatty acid testing at ~8–12 weeks.

Qualitative Assessment

  • Frequency and duration of colds and minor infections over a season
  • Digestive comfort, regularity, and stool quality
  • Bloating or gas (should diminish as the gut adapts)
  • General energy and sense of well-being
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.